Literature DB >> 16731906

Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1.

Kazuo Nishigaki1, Charlotte Hanson, Takashi Ohashi, Angelo Spadaccini, Sandra Ruscetti.   

Abstract

Infection of mice with Friend spleen focus-forming virus (SFFV) results in a multistage erythroleukemia. In the first stage, the SFFV envelope glycoprotein interacts with the erythropoietin receptor and a short form of the receptor tyrosine kinase sf-Stk, resulting in constitutive activation of signal transducing molecules and the development of erythropoietin (Epo)-independent erythroid hyperplasia and polycythemia. The second stage results from the outgrowth of a rare virus-infected erythroid cell that expresses nonphysiological levels of the myeloid transcription factor PU.1. These cells exhibit a differentiation block and can be grown as murine erythroleukemia (MEL) cell lines. In this study, we examined SFFV MEL cells to determine whether their transformed phenotype was associated with a block in the activation of any Epo signal-transducing molecules. Our studies indicate that Epo- or SFFV-induced activation of STAT1/3 DNA binding activity is blocked in SFFV MEL cells. The block is at the level of tyrosine phosphorylation of STAT1, although Jak2 phosphorylation is not blocked in these cells. In contrast to Epo, alpha interferon can induce STAT1 phosphorylation and DNA binding in SFFV MEL cells. The SFFV-transformed cells were shown to express elevated levels of the hematopoietic phosphatase SHP-1, and treatment of the cells with a phosphatase inhibitor restored STAT1 tyrosine phosphorylation. MEL cells derived from Friend murine leukemia virus (MuLV) or ME26 MuLV-infected mice, which do not express PU.1, express lower levels of SHP-1 and are not blocked in STAT1/3 DNA-binding activity. Our studies suggest that SFFV-infected erythroid cells become transformed when differentiation signals activated by STAT1/3 are blocked due to high SHP-1 levels induced by inappropriate expression of the PU.1 protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731906      PMCID: PMC1472600          DOI: 10.1128/JVI.02651-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.

Authors:  F W Quelle; D Wang; T Nosaka; W E Thierfelder; D Stravopodis; Y Weinstein; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 2.  Deregulation of erythropoiesis by the Friend spleen focus-forming virus.

Authors:  S K Ruscetti
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

3.  Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.

Authors:  S Schuetze; R Paul; B C Gliniak; D Kabat
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

4.  Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene.

Authors:  L D Shultz; P A Schweitzer; T V Rajan; T Yi; J N Ihle; R J Matthews; M L Thomas; D R Beier
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

5.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

Authors:  B A Witthuhn; F W Quelle; O Silvennoinen; T Yi; B Tang; O Miura; J N Ihle
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

6.  Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus.

Authors:  T Ohashi; M Masuda; S K Ruscetti
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

7.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.

Authors:  U Klingmüller; U Lorenz; L C Cantley; B G Neel; H F Lodish
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

8.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.

Authors:  A de la Chapelle; A L Träskelin; E Juvonen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

9.  Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites.

Authors:  T Yi; J Zhang; O Miura; J N Ihle
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

10.  Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.

Authors:  F Gouilleux; C Pallard; I Dusanter-Fourt; H Wakao; L A Haldosen; G Norstedt; D Levy; B Groner
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  7 in total

1.  Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease.

Authors:  Daigo Umehara; Shinya Watanabe; Haruyo Ochi; Yukari Anai; Nursarat Ahmed; Mari Kannagi; Charlotte Hanson; Sandra Ruscetti; Kazuo Nishigaki
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation.

Authors:  Tanya M Jelacic; Delores Thompson; Charlotte Hanson; Joan L Cmarik; Kazuo Nishigaki; Sandra Ruscetti
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

3.  Role of N-terminal sequences of the tyrosine kinase sf-Stk in transformation of rodent fibroblasts by variants of Friend spleen focus-forming virus.

Authors:  Daigo Umehara; Maki Kawamura; Yuka Odahara; Shinya Watanabe; Charlotte Hanson; Sandra Ruscetti; Kazuo Nishigaki
Journal:  Int J Cancer       Date:  2011-12-05       Impact factor: 7.396

4.  Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice.

Authors:  Joan Cmarik; Sandra Ruscetti
Journal:  Viruses       Date:  2010-10-11       Impact factor: 5.818

5.  DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation.

Authors:  María José Fernández-Nestosa; Estefanía Monturus; Zunilda Sánchez; Francisco S Torres; Agustín F Fernández; Mario F Fraga; Pablo Hernández; Jorge B Schvartzman; Dora B Krimer
Journal:  Springerplus       Date:  2013-08-21

6.  Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling.

Authors:  Elena V Efimova; Hua Liang; Sean P Pitroda; Edwardine Labay; Thomas E Darga; Vera Levina; Anna Lokshin; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Int J Radiat Biol       Date:  2009-05       Impact factor: 2.694

Review 7.  Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation.

Authors:  Françoise Moreau-Gachelin
Journal:  Retrovirology       Date:  2008-11-04       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.